• Product NameFosinopril sodium
• Brief DescriptionInhibitors
• Purification99.37%
• Biological ActivityFosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor, used for the treatment of hypertension and some types of chronic heart failure.
• Target NameRAAS inhibitor
• CAS No. 88889-14-9
• Calculated MW 586.65
• Formulation C30H45NO7PNa
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3.[Na+]
  Pathways:Endocrinology/Hormones
  Receptor:ACE
  Boling pt:
  Melting pt:196-198C
  Solubility:Ethanol: 4 mg/mL (6.83 mM); Water: 117 mg/mL (199.78 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Sharma S, et al. Fosinopril Hemodynamics Study Group. Am J Ther. 1999 Jul;6(4):181-9.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting